ERIS LIFESCIENCES
Back to Cashflow Statement
|
ERIS LIFESCIENCES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,065 Cr | ₹486 Cr | ₹292 Cr | ₹378 Cr | ₹375 Cr |
What is the latest Cash Flow from Operating Activities ratio of ERIS LIFESCIENCES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹1,065 Cr |
| Mar2024 | ₹486 Cr |
| Mar2023 | ₹292 Cr |
| Mar2022 | ₹378 Cr |
| Mar2021 | ₹375 Cr |
How is Cash Flow from Operating Activities of ERIS LIFESCIENCES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,065 Cr | 119.13 | |
| Mar2024 | ₹486 Cr | 66.59 | |
| Mar2023 | ₹292 Cr | -22.87 | |
| Mar2022 | ₹378 Cr | 0.77 | |
| Mar2021 | ₹375 Cr | - | |
Compare Cash Flow from Operating Activities of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹18,830.2 Cr | -2.4% | -8.7% | -18.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | -2.4% |
-8.7% |
-18.6% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses